These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28398272)

  • 21. [Prognostic factors in patients with castration-resistant prostate cancer].
    Furuse H; Ozono S
    Nihon Rinsho; 2016 May; 74 Suppl 3():171-5. PubMed ID: 27344724
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening of visceral metastasis in castration-resistant prostate cancer: a cornerstone in personalized patient's care.
    Grobet-Jeandin E; Valerio M
    Prostate Cancer Prostatic Dis; 2023 Mar; 26(1):3-4. PubMed ID: 36203050
    [No Abstract]   [Full Text] [Related]  

  • 23. When to initiate treatment with radium-223 in patients with metastatic castration-resistant prostate cancer.
    Shore ND
    Clin Adv Hematol Oncol; 2016 Jan; 14(1):26-9. PubMed ID: 27057663
    [No Abstract]   [Full Text] [Related]  

  • 24. A comprehensive review of genomic landscape, biomarkers and treatment sequencing in castration-resistant prostate cancer.
    Seisen T; Rouprêt M; Gomez F; Malouf GG; Shariat SF; Peyronnet B; Spano JP; Cancel-Tassin G; Cussenot O
    Cancer Treat Rev; 2016 Jul; 48():25-33. PubMed ID: 27327958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Not Available].
    Bernemann C; Bögemann M; Steinestel J; Schrader AJ
    Oncol Res Treat; 2017; 40 Suppl 2():8-10. PubMed ID: 28365708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy.
    Kang YJ; Jang WS; Kwon JK; Yoon CY; Lee JY; Ham WS; Choi YD
    BMC Cancer; 2017 Nov; 17(1):789. PubMed ID: 29169347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies.
    Dillinger T; Sheibani-Tezerji R; Pulverer W; Stelzer I; Hassler MR; Scheibelreiter J; Pérez Malla CU; Kuroll M; Domazet S; Redl E; Ely S; Brezina S; Tiefenbacher A; Rebhan K; Hübner N; Grubmüller B; Mitterhauser M; Hacker M; Weinhaeusel A; Simon J; Zeitlinger M; Gsur A; Kramer G; Shariat SF; Kenner L; Egger G
    Mol Cancer; 2022 Jan; 21(1):7. PubMed ID: 34980142
    [No Abstract]   [Full Text] [Related]  

  • 28. The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
    Geethakumari PR; Cookson MS; Kelly WK;
    Oncology (Williston Park); 2016 Feb; 30(2):187-95, 199. PubMed ID: 26888794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of microRNA in castration-resistant prostate cancer.
    Thieu W; Tilki D; de Vere White R; Evans CP
    Urol Oncol; 2014 Jul; 32(5):517-523. PubMed ID: 24935732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The predictive value of ERG protein expression for development of castration-resistant prostate cancer in hormone-naïve advanced prostate cancer treated with primary androgen deprivation therapy.
    Berg KD; Røder MA; Thomsen FB; Vainer B; Gerds TA; Brasso K; Iversen P
    Prostate; 2015 Oct; 75(14):1499-509. PubMed ID: 26053696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Castration-Resistant Prostate Cancer: Mechanisms, Targets and Treatment.
    Mansinho A; Macedo D; Fernandes I; Costa L
    Adv Exp Med Biol; 2018; 1096():117-133. PubMed ID: 30324351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life in men with metastatic castration-resistant prostate cancer.
    Gee A; Challapalli A; Bahl A
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):941-9. PubMed ID: 26512743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Testosterone in the management of metastatic prostate cancer].
    Wolff JM; Schmid HP
    Urologe A; 2015 Nov; 54(11):1578-83. PubMed ID: 26113300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New developments in the imaging of metastatic prostate cancer.
    Beauregard JM; Pouliot F
    Curr Opin Support Palliat Care; 2014 Sep; 8(3):265-70. PubMed ID: 25004180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 2-Gene Panel Derived From Prostate Cancer-Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration-Resistant Prostate Cancer.
    Heck MM; Thalgott M; Schmid SC; Oh WK; Gong Y; Wang L; Zhu J; Seitz AK; Porst D; Höppner M; Retz M; Gschwend JE; Nawroth R
    Prostate; 2016 Sep; 76(13):1160-8. PubMed ID: 27198487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer.
    Uemura K; Miyoshi Y; Kawahara T; Yoneyama S; Hattori Y; Teranishi J; Kondo K; Moriyama M; Takebayashi S; Yokomizo Y; Yao M; Uemura H; Noguchi K
    BMC Cancer; 2016 Feb; 16():109. PubMed ID: 26883015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation and diagnosis for castration resistant prostate cancer: CRPC].
    Kamoto T
    Nihon Rinsho; 2014 Dec; 72(12):2103-7. PubMed ID: 25518341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current management of advanced and castration resistant prostate cancer.
    Gomella LG; Petrylak DP; Shayegan B
    Can J Urol; 2014 Apr; 21(2 Supp 1):1-6. PubMed ID: 24775717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Open University's first one-day symposium on treatment-emergent neuroendocrine prostate cancer.
    Mather RL; Andrews H; Pandha H; Jachetti E; Micallef J; Wang Y; Crea F
    Future Oncol; 2020 Feb; 16(6):147-149. PubMed ID: 31964195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical phenotypes of castration-resistant prostate cancer.
    Zhang T; Armstrong AJ
    Clin Adv Hematol Oncol; 2013 Nov; 11(11):707-18. PubMed ID: 24896544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.